‰»Šw‰οŽΠ‚ΜŠCŠOioˆκ—— “c•ΣŽO•H»–ς ‰’B

ˆγ–ς•i‚̐»‘’”Μ”„

ŽΠ–Ό Mitsubishi Tanabe Pharma Europe Ltd.

‹ŒΜ@Mitsubishi Pharma Europe Ltd.@© MTP Europe Ltd.
κŠ London
Š”Žε “c•ΣŽO•H»–ς@100%

“–‰ ŽO•H“Œ‹ž»–ς 100%
έ—§ 2001
”\—Ν  
”υl Mitsubishi Pharma Europe Ltd.
@@‹ŒƒEƒFƒ‹ƒtƒ@ƒCƒhŽΠ‚Μƒƒ“ƒhƒ“Ž––±Š‚𓝍‡A‹ŒMTP Europe‚π”­“W“I‚Ι‰ό‘g
2014/6/1 ‰όΜ
@@http://www.mt-pharma.co.jp/shared/show.php?url=../release/nr/2014/MTPC140528.html


 

ŽΠ–Ό Mitsubishi Tanabe Pharma GmbH

‹ŒΜ@ŽO•Hƒtƒ@[ƒ} ƒhƒCƒc
κŠ Duesseldorf, Germany
Š”Žε Mitsubishi Tanabe Pharma Europe Ltd.@100%
έ—§  
”\—Ν  
”υl 2014/6/1 ‰όΜ
@@http://www.mt-pharma.co.jp/shared/show.php?url=../release/nr/2014/MTPC140528.html

@

ˆγ–ς•iŒ΄––‚̐»‘’E”Μ”„

ŽΠ–Ό Synthelabo-Tanabe Chimie S.A.
κŠ  
Š”Žε “c•ΣŽO•H»–ςiŒ³‚Ν“c•Σ»–ςj 50%
Sanofi Aventis 50%
έ—§ 1987/6
”\—Ν  
”υl  

@

ŒŒŸχ•ͺ‰ζŽ–‹Ζ    ¨@”„‹p

ŽΠ–Ό ƒAƒ‹ƒtƒ@EƒOƒŠƒtƒHƒ‹ƒX‚r‚`
κŠ ƒXƒyƒCƒ“
Š”Žε  
έ—§  
”\—Ν  
”υl 1982 ƒ~ƒhƒŠ\Žš‚̕č‘Žq‰οŽΠ Green Cross Int'l ‚Ζ‚»‚ΜŽq‰οŽΠ Alpha Therapeutic ‚ͺ 50%oŽ‘
1999 Ž•ͺ”„‹p

 
@